Literature DB >> 12203224

High-resolution magic angle spinning MRS of breast cancer tissue.

Beathe Sitter1, Ursula Sonnewald, Manfred Spraul, Hans E Fjösne, Ingrid S Gribbestad.   

Abstract

High-resolution magic angle spinning (HR MAS) may develop into a new diagnostic tool for studying intact tissue samples, and several types of cancer have been investigated with promising results. In this study HR MAS spectra of breast cancer tissue from 10 patients have been compared to conventional high-resolution spectra of perchloric acid extracts of the same tissue type. The HR MAS spectra show resolution comparable to spectra of extracts, and two-dimensional techniques lead to identification of a majority of the constituents. More than 30 different metabolites have been detected and assigned. To our knowledge this is the most detailed assignment of biochemical components in intact human breast tissue. The spectra of intact breast cancer tissue differ from perchloric acid extracts by the presence of lipids and fewer signals in the low field region. HR MAS analysis of intact breast tissue specimens is a rapid method, providing spectra with resolution where relative quantification of the majority of the detected metabolites is possible. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203224     DOI: 10.1002/nbm.775

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  78 in total

1.  In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model.

Authors:  Min-Hui Cui; Craig A Branch; Sean M Cahill; Thomas J Quinn; Asha Adem; Steven K Libutti; Ziqiang Yuan
Journal:  Magn Reson Med       Date:  2014-11-13       Impact factor: 4.668

2.  Short-term temperature effect on the HRMAS spectra of human brain tumor biopsies and their pattern recognition analysis.

Authors:  Daniel Valverde-Saubí; Ana Paula Candiota; Maria Antònia Molins; Miguel Feliz; Oscar Godino; Myriam Dávila; Juan José Acebes; Carles Arús
Journal:  MAGMA       Date:  2010-06-13       Impact factor: 2.310

Review 3.  Metabonomics techniques and applications to pharmaceutical research & development.

Authors:  John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

Review 4.  Metabolite quantification and high-field MRS in breast cancer.

Authors:  Ihab S Haddadin; Adeka McIntosh; Sina Meisamy; Curt Corum; Angela L Styczynski Snyder; Nathaniel J Powell; Michael T Nelson; Douglas Yee; Michael Garwood; Patrick J Bolan
Journal:  NMR Biomed       Date:  2009-01       Impact factor: 4.044

5.  Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.

Authors:  Maria Dung Cao; Menglin Cheng; Asif Rizwan; Lu Jiang; Balaji Krishnamachary; Zaver M Bhujwalla; Tone F Bathen; Kristine Glunde
Journal:  NMR Biomed       Date:  2016-06-30       Impact factor: 4.044

6.  NMR-spectroscopy for nontargeted screening and simultaneous quantification of health-relevant compounds in foods: the example of melamine.

Authors:  Dirk W Lachenmeier; Eberhard Humpfer; Fang Fang; Birk Schütz; Peter Dvortsak; Constanze Sproll; Manfred Spraul
Journal:  J Agric Food Chem       Date:  2009-08-26       Impact factor: 5.279

Review 7.  Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS).

Authors:  Uma Sharma; Naranamangalam R Jagannathan
Journal:  Biophys Rev       Date:  2009-01-17

8.  Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.

Authors:  Kejia Cai; He N Xu; Anup Singh; Lily Moon; Mohammad Haris; Ravinder Reddy; Lin Z Li
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

Review 9.  Multiparametric MR Imaging of Breast Cancer.

Authors:  Habib Rahbar; Savannah C Partridge
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

10.  Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers.

Authors:  Alan J Wright; Greg A Fellows; John R Griffiths; M Wilson; B Anthony Bell; Franklyn A Howe
Journal:  Mol Cancer       Date:  2010-03-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.